#neuroprotection — Thursday, July 09, 2026 (1 items)
| 0 | 💬 0 |
Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1/2 open-label trial.
(nature.com)
|
Nature Medicine 2026-07-09 | #neurodegeneration #stem-cells #transplantation #immunosuppression #neuroprotection |